Sökning: "natriuretic peptide"
Visar resultat 1 - 5 av 90 avhandlingar innehållade orden natriuretic peptide.
1. The endocrine heart - metabolic actions of atrial natriuretic peptide
Sammanfattning : Abstract The natriuretic peptides (NPs), namely atrial natriuretic peptide (ANP) and bran natriuretic peptide (BNP), which are secreted from cardiomyocytes in response to cardiac wall stress, play a significant role in the regulation of blood pressure, intravascular volume, and cardiac remodeling. Recently, NPs emerged as hormones with metabolic actions such as inhibition of the renin-angiotensin system and inhibition of inflammation, together with lipolysis and adipose tissue browning. LÄS MER
2. Nitrates and Left Ventricular Dysfunction
Sammanfattning : Use of beta-blockers and inhibitors of the renin angiotensin system (RAS) is established practice in the treatment of chronic heart failure (CHF). Clinical studies also suggest beneficial long-term effects of nitrates in CHF. LÄS MER
3. Preeclampsia – Studies on the Placenta and B-type Natriuretic Peptide
Sammanfattning : Preeclampsia has several pathophysiological pathways, but the placenta has a central role. The pathophysiology appears to differ between the two subtypes – early- and late-onset preeclampsia. LÄS MER
4. Atrial natriuretic peptide in ischaemic acute renal failure
Sammanfattning : .... LÄS MER
5. Early Risk Stratification, Treatment and Outcome in ST-elevation Myocardial Infarction
Sammanfattning : We evaluated, in patients with ST-elevation myocardial infarction (STEMI) treated with thrombolytics, admission Troponin T (tnT), ST-segment resolution and admission N-terminal pro-brain natriuretic peptide (NT-proBNP) for early risk stratification as well as time delays and outcome in real life patients according to prehospital or in-hospital thrombolytic treatment. Also, baseline characteristics, treatments and outcome in patients enrolled in the ASSENT-2 trial in Sweden and in patients not enrolled were evaluated. LÄS MER